ArticleAACE endocrinology and diabetes
Coexistence of Hyalinizing Trabecular Tumor and Papillary Thyroid Carcinoma: A Diagnostic Challenge.
Article in AACE endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Objective: Hyalinizing trabecular tumor (HTT) of the thyroid is an uncommon follicular cell-derived neoplasm. Histologically, it shares several nuclear features with papillary thyroid carcinoma (PTC), such as nuclear grooves and pseudoinclusions, making accurate diagnosis challenging, particularly in cytology. Coexistence of HTT and PTC within the same thyroid gland is exceptionally rare and can further complicate clinical interpretation. Case Report: A 54-year-old woman presented with a gradually enlarging anterior neck swelling. Ultrasound revealed 2 nodules in the right thyroid lobe with differing echogenic features. Fine-needle aspiration cytology was reported as Bethesda Category III (Atypia of Undetermined Significance). A right lobectomy was performed for definitive diagnosis. Histopathology revealed 2 distinct lesions: a 1.2 cm hyalinizing trabecular tumor showing trabecular architecture, hyalinized stroma, CD56 positivity, and characteristic membranous Ki-67 staining; and an incidental 0.1 cm papillary thyroid carcinoma exhibiting fibrovascular cores with nuclear clearing and grooves, CK19 positivity, and CD56 loss. No capsular, vascular, or extrathyroidal invasion was identified. The patient recovered uneventfully and remains disease-free after 2.5 years of follow-up. Discussion: The coexistence of HTT and PTC within the same thyroid gland is a rare but documented phenomenon, reported in only a few cases worldwide. The morphologic overlap between HTT and PTC frequently leads to diagnostic uncertainty in cytology. Immunohistochemistry and, when available, molecular testing for GLIS1/GLIS3 rearrangements provide essential diagnostic clarity. Conclusion: This case underscores the importance of integrating cytologic, histopathologic, and molecular features when evaluating thyroid nodules with overlapping characteristics. Recognition of this rare coexistence prevents misclassification and unnecessary aggressive management, ensuring accurate diagnosis and optimal patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.